WBA Logo

Walgreens Boots Alliance, Inc. (WBA) 

NASDAQ
Market Cap
$8.25B
Sector
Healthcare
Industry
Medical—Pharmaceuticals
Rank in Sector
183 of 960
Rank in Industry
2 of 6

Largest Insider Buys in Sector

WBA Stock Price History Chart

WBA Stock Performance

About Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane …

Insider Activity of Walgreens Boots Alliance, Inc.

Over the last 12 months, insiders at Walgreens Boots Alliance, Inc. have bought $512,643 and sold $350,567 worth of Walgreens Boots Alliance, Inc. stock.

On average, over the past 5 years, insiders at Walgreens Boots Alliance, Inc. have bought $499,568 and sold $398,000 worth of stock each year.

Highest buying activity among insiders over the last 12 months: WENTWORTH TIMOTHY C (Chief Executive Officer) — $484,440. JARRETT VALERIE B (director) — $299,978. Mahajan Manmohan (EVP and Global CFO) — $116,280.

The last purchase of 3,000 shares for transaction amount of $54,150 was made by Bhandari Inderpal S (director) on 2024‑04‑11.

List of Insider Buy and Sell Transactions, Walgreens Boots Alliance, Inc.

2024-04-11Purchasedirector
3,000
0.0003%
$18.05$54,150-40.93%
2024-04-02PurchaseEVP and Global CFO
6,000
0.0007%
$19.38$116,280-42.39%
2024-01-29Purchasedirector
4,456
0.0005%
$22.44$99,993-31.09%
2024-01-16Saledirector
15,209
0.0018%
$23.05$350,567-30.67%
2024-01-05PurchaseChief Executive Officer
10,000
0.0011%
$24.22$242,220-35.66%
2023-11-10SaleSVP, Chief Pharmacy Officer
1,000
0.0001%
$20.45$20,450-13.14%
2023-06-30PurchaseEVP, Pres. U.S. Healthcare
5,172
0.0006%
$28.42$146,984-23.94%
2023-03-29PurchaseCEO
10,000
0.0012%
$33.95$339,510-28.17%
2022-11-18SaleEVP, Chief Medical Officer
10,303
0.0012%
$40.19$414,108-18.41%
2022-11-17Saledirector
16,570
0.0019%
$39.89$660,928-19.14%
2021-11-19Saledirector
2,725
0.0003%
$47.16$128,497-6.94%
2020-11-11SaleEVP, Global CAO and GC
10,000
0.0012%
$41.55$415,450+21.52%
2019-11-05SaleEVP, Global CAO and GC
468,710
0.0543%
$63.16$29.6M-28.46%
2019-08-15SaleEVP, Global CAO and GC
246,992
0.0272%
$50.06$12.36M+3.23%
2019-08-14SaleEVP, Global CAO and GC
183,654
0.0202%
$51.03$9.37M+0.91%
2019-05-09SaleEVP, Global CAO and GC
40,000
0.0044%
$53.05$2.12M+0.56%
2019-04-03PurchaseCo-Chief Operating Officer
36,000
0.0039%
$54.56$1.96M-0.93%
2018-11-20Saledirector
14,100
0.0015%
$78.81$1.11M-29.63%
2018-11-01Saledirector
5,472
0.0006%
$79.48$434,915-29.34%
2018-11-01SaleSVP, Global Controller and CAO
15,705
0.0017%
$79.79$1.25M-29.34%

Insider Historical Profitability

<0.0001%
WENTWORTH TIMOTHY CChief Executive Officer
585122
0.0678%
$9.5510
Mahajan ManmohanEVP and Global CFO
166969
0.0193%
$9.5510
JARRETT VALERIE Bdirector
4456
0.0005%
$9.5510
Bhandari Inderpal Sdirector
3000
0.0003%
$9.5510
Pessina StefanoExecutive Vice Chairman, CEO
144788821
16.7679%
$9.5531+4.43%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$1.78B9.5382.26M-1.06%-$19.1M0.03
BlackRock$1.48B7.8968.13M+3.4%+$48.58M0.03
State Street$785.04M4.1936.19M-33.2%-$390.11M0.03
Capital World Investors$630.33M3.3729.06M+57.52%+$230.18M0.11
Geode Capital Management$409.49M2.1918.88M+13.99%+$50.25M0.04
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.